Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome

Condition(s) studied

Investigational drug(s) / intervention(s)

the Castor single branch stent graft: Participants who received thoracic endovascular aortic repair by meant of the Castor single branch stent graft from June 2018 to June 2022 were enrolled in our study.

Study summary

The objective of this study to evaluate the safety and effectiveness of the Castor single branch stent graft for endovascular repair of acute aortic syndrome patients without an inadequate proximal landing zone (\<15mm)

Eligibility

Primary outcome measure(s)

• Immediate post-operative technique success — immediately post operation
  Immediate technical success is defined as successful delivery of the aortic and branching stent graft conveyors to their predetermined position, accurate positioning and successful deployment of the stent, safe removal of the delivery device outside the body, absence of Type I and III endoleaks on angiography at the end of the procedure, and patent branch stents.
• All-cause mortality and major — 1-year post operation
  All-cause mortality includes aortic mortality, non-aortic mortality, and mortality from unknown causes.

Trial sites (1)

More First Affiliated Hospital Xi'an Jiaotong University trials in China

Other trials for the same condition